Literature DB >> 6472359

Cyclosporin-induced nephrotoxicity. Inevitable and intractable?

T B Strom, R Loertscher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6472359     DOI： 10.1056/NEJM198409133111109

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Renal transplantation.

Authors:  R S Trompeter
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

Review 2.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

3.  Cyclosporin therapy in Mooren's ulcer.

Authors:  D Wakefield; L P Robinson
Journal:  Br J Ophthalmol       Date:  1987-06       Impact factor: 4.638

4.  Effect of cyclosporin on serum creatinine in patients with rheumatoid arthritis.

Authors:  B A Dijkmans; A W van Rijthoven; H S Goei The; Z L Montnor-Beckers; P C Jacobs; A Cats
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts.

Authors:  G H Neild; D H Taube; R B Hartley; L Bignardi; J S Cameron; D G Williams; C S Ogg; C J Rudge
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

6.  The effect of donor-specific transfusion and cyclosporin A on small bowel transplantation in the rat.

Authors:  S F Santiago; M Fukuzawa; T Azuma; R Nezu; K Imura; Y Takagi; A Okada
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

7.  Histological lesions associated with cyclosporin: incidence and reversibility in one year old kidney transplants.

Authors:  D J Versluis; F J Ten Kate; G J Wenting; J Jeekel; W Weimar
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

8.  Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA2-Mediated Activation.

Authors:  Milica Markovic; Karina Abramov-Harpaz; Clil Regev; Shimon Ben-Shabat; Aaron Aponick; Ellen M Zimmermann; Yifat Miller; Arik Dahan
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

9.  PLA2-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy.

Authors:  Milica Markovic; Shimon Ben-Shabat; Jagadeesh Nagendra Manda; Karina Abramov-Harpaz; Clil Regev; Yifat Miller; Aaron Aponick; Ellen M Zimmermann; Arik Dahan
Journal:  Pharmaceutics       Date:  2022-03-18       Impact factor: 6.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.